Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

René J E Grouls

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Journal of Hospital Pharmacy : Science and Practice|September 26, 2020
Dabigatran trough concentrations in very elderly patientsEllis Gommans, René J E Grouls, Daan Kerkhof, et al.
Drug Safety|June 18, 2010
Recurrence of adverse drug reactions following inappropriate re-prescription: better documentation, availability of information and monitoring are neededCarolien M J van der Linden, Paul A F Jansen, Rob J van Marum, et al.
Drugs & Aging|November 13, 2012
An electronic system to document reasons for medication discontinuation and to flag unwanted represcriptions in geriatric patientsCarolien M J van der Linden, Paul A F Jansen, Rob J van Marum, et al.
Pharmacy (Basel, Switzerland)|April 27, 2023
The Effect of Genotyping on the Number of Pharmacotherapeutic Gene-Drug Interventions in Chronic Kidney Disease PatientsCatharina H M Kerskes, Carien J M E van den Eijnde, Albert-Jan L H J Aarnoudse, et al.
Therapeutic Advances in Drug Safety|August 2, 2014
Systems that prevent unwanted represcription of drugs withdrawn because of adverse drug events: a systematic reviewCarolien M J van der Linden, Paul A F Jansen, René J E Grouls, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Journal of Hospital Pharmacy : Science and Practice|September 26, 2020
Dabigatran trough concentrations in very elderly patientsEllis Gommans, René J E Grouls, Daan Kerkhof, et al.
Drug Safety|June 18, 2010
Recurrence of adverse drug reactions following inappropriate re-prescription: better documentation, availability of information and monitoring are neededCarolien M J van der Linden, Paul A F Jansen, Rob J van Marum, et al.
Drugs & Aging|November 13, 2012
An electronic system to document reasons for medication discontinuation and to flag unwanted represcriptions in geriatric patientsCarolien M J van der Linden, Paul A F Jansen, Rob J van Marum, et al.
Pharmacy (Basel, Switzerland)|April 27, 2023
The Effect of Genotyping on the Number of Pharmacotherapeutic Gene-Drug Interventions in Chronic Kidney Disease PatientsCatharina H M Kerskes, Carien J M E van den Eijnde, Albert-Jan L H J Aarnoudse, et al.
Therapeutic Advances in Drug Safety|August 2, 2014
Systems that prevent unwanted represcription of drugs withdrawn because of adverse drug events: a systematic reviewCarolien M J van der Linden, Paul A F Jansen, René J E Grouls, et al.
Pageof 1